[In vitro studies on immunosuppression with verapamil].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Transliterated Title:
      In-vitro-Untersuchungen zur Immunsuppression mit Verapamil.
    • Source:
      Publisher: Thieme Country of Publication: Germany NLM ID: 0413645 Publication Model: Print Cited Medium: Print ISSN: 0044-409X (Print) Linking ISSN: 0044409X NLM ISO Abbreviation: Zentralbl Chir Subsets: MEDLINE
    • Publication Information:
      Publication: <2009- > : Stuttgart : Thieme
      Original Publication: Leipzig : Johann Ambrosius Barth
    • Subject Terms:
      Calmodulin/*antagonists & inhibitors ; Chemotaxis, Leukocyte/*drug effects ; Lymphocyte Activation/*drug effects ; Protein Kinase C/*antagonists & inhibitors ; Verapamil/*pharmacology; Calmodulin/physiology ; Cell Adhesion Molecules/physiology ; Cell Survival/drug effects ; Cells, Cultured ; Chemotaxis, Leukocyte/immunology ; Dose-Response Relationship, Drug ; Endothelium, Vascular/immunology ; Humans ; Immune Tolerance/drug effects ; Immune Tolerance/immunology ; Lymphocyte Activation/immunology ; Microscopy, Fluorescence ; Protein Kinase C/physiology ; Second Messenger Systems/drug effects ; Second Messenger Systems/immunology ; Verapamil/toxicity
    • Abstract:
      Unlabelled: AIMS OF THE INVESTIGATION: It is known that Verapamil and other calcium channel blockers possess immunosuppressive properties. It has been suggested that they exert their effects by antagonising protein kinase C (PKC) or calmodulin. Our aim was to investigate whether the adhesion of lymphocytes to allogenic endothelial cells and lymphocyte migration are impaired in the presence of Verapamil. The role of PKC and calmodulin during expression of adhesion molecules, the expression of adhesion molecules under the influence of Verapamil and lymphocyte motility on endothelial cell monolayers were investigated.
      Methods: Human endothelial cells (EC) were obtained from umbilical chord veins and incubated as dissociate primary cultures. Expression of adhesion molecules on EC was determined by quantitative immunofluorescence using the CytoFluor 2300-system. Studies on lymphocyte motility were performed by phase contrast microscopy using video scope analysis.
      Results: Expression of Intercellular Adhesion Molecule 1 (ICAM-1), Vascular Cell Adhesion Molecule (VCAM-1) and Endothelial Leukocyte Adhesion Molecule I (ELAM-1) was dose-dependently reduced by the application of PKC-inhibitor H7. Expression of ICAM-1 and VCAM-1 was also inhibited by the calmodulin-antagonist W7. Surprisingly, neither R- nor S-Verapamil inhibited adhesion molecule expression, we even observed significant enhancement of ELAM-1- and ICAM-1-expression. Nevertheless, lymphocyte motility on allogenic EC monolayers was impaired in the presence of R-verapamil, the enantiomer that is inactive as a calcium channel blocker.
      Conclusion: Verapamil reduces lymphocyte motility and is therefore effective in impairing lymphocyte-endothelial cell-interactions. These effects seem to be independent of calcium channel blockade and are probably not due to inhibition of PKC or calmodulin.
    • Accession Number:
      0 (Calmodulin)
      0 (Cell Adhesion Molecules)
      CJ0O37KU29 (Verapamil)
      EC 2.7.11.13 (Protein Kinase C)
    • Publication Date:
      Date Created: 19940101 Date Completed: 19940804 Latest Revision: 20131121
    • Publication Date:
      20231215
    • Accession Number:
      8023602